Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
NCT ID: NCT07090161
Last Updated: 2026-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2
240 participants
INTERVENTIONAL
2025-09-15
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled Hypertension
NCT05314439
Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients
NCT04820907
The Effects of Antihypertensive Agents on Central Blood Pressure in Healthy Participants and Participants With Hypertension (MK-0000-166) (COMPLETED)
NCT01130168
Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension
NCT00994617
Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy
NCT00956644
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental/Iloperidone
iloperidone
iloperidone
Placebo Comparator
Placebo
placebo comparator
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iloperidone
iloperidone
Placebo
placebo comparator
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanda Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanda Investigative Site
Phoenix, Arizona, United States
Vanda Investigative Site
Tempe, Arizona, United States
Vanda Investigative Site
Tucson, Arizona, United States
Vanda Investigative Site
Chula Vista, California, United States
Vanda Investigative Site
Dublin, California, United States
Vanda Investigative Site
Valencia, California, United States
Vanda Investigative Site
Walnut Creek, California, United States
Vanda Investigative Site
Doral, Florida, United States
Vanda Investigative Site
Fort Myers, Florida, United States
Vanda Investigative Site
Columbus, Georgia, United States
Vanda Investigative Site
Oak Brook, Illinois, United States
Vanda Investigative Site
Tinley Park, Illinois, United States
Vanda Investigative Site
El Dorado, Kansas, United States
Vanda Investigative Site
Wichita, Kansas, United States
Vanda Investigative Site
Lexington, Kentucky, United States
Vanda Investigative Site
Hazelwood, Missouri, United States
Vanda Investigative Site
Las Vegas, Nevada, United States
Vanda Investigative Site
Mount Kisco, New York, United States
Vanda Investigative Site
Rochester, New York, United States
Vanda Investigative Site
Kinston, North Carolina, United States
Vanda Investigative Site
Cincinnati, Ohio, United States
Vanda Investigative Site
Norman, Oklahoma, United States
Vanda Investigative Site
Oklahoma City, Oklahoma, United States
Vanda Investigative Site
Charleston, South Carolina, United States
Vanda Investigative Site
Carrollton, Texas, United States
Vanda Investigative Site
Salt Lake City, Utah, United States
Vanda Investigative Site
Burke, Virginia, United States
Vanda Investigative Site
Norfolk, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VP-VYV-683-2401
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.